Skip to main content

Table 2 Supplementation impact on malaria and general morbidity

From: Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial

  Placebo Supplemented RR (95% CI) p-value
Number of fever episodes (mean ± SD) 2.04 ± 1.2 1.63 ± 1.2 - 0.038
Number of malaria episodes (mean ± SD) 1.5 ± 1.005 1 ± 0.93 - 0.029
P*PFever episodes 153 119 1.28 (1.09–2.94) 0.030
P*PMalaria episodes 106 74 1.43 (1.10–2.40) 0.025
Free of pathologies 17% (9–25) 31% (16–46) - 0.05
Cough episodes 51,3 (40–62.6) 45,9% (34.6–57.2) - 0.510
Diarrhea episodes 52,7% (41.4–64) 28,3% (18.1–38.5) - 0.002
Geometric mean density P falciparum (asexual forms/μl) 10672 (7589–15007) 7704 (5409–10971) - 0.049
  1. P*PNumber of episodes
  2. Mean ± SD or % (CI 95%)
  3. Child-years was 37 in each group